Transcription of 2010 DoD US Inside - seanmeskill.com
{{id}} {{{paragraph}}}
2010 dialysis of DrugsCurtis A. Johnson, PharmDCKD Insights, LLCV erona, WisconsinandProfessor (Emeritus) of Pharmacy and MedicineUniversity of Wisconsin-MadisonMadison, Wisconsin2010 dialysis of Drugs2 SEE DISCLAIMER REGARDING USE OF THIS GUIDEDISCLAIMER These dialysis of Drugs guidelines are offered as a general summary of information for pharmacists and other medical professionals. Inappropriate administration of drugs may involve serious medical risks to the patient that can only be identifi ed by medical professionals. Depending on the circumstances, the risks can be serious and can include severe injury, including death.
2010 Dialysis of Drugs 6 SEE DISCLAIMER REGARDING USE OF THIS GUIDE patients, renal clearance is largely replaced by dialysis clearance. If nonrenal clearance is large
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Argatroban for anticoagulation in continuous renal, Argatroban for anticoagulation in continuous renal replacement therapy, IV ANTI-INFECTIVE MEDICATION DOSING IN, Continuous Renal Replacement Therapy, RENAL REPLACEMENT THERAPY IN CRITICAL CARE, Potassium Replacement, Recommendations: Other Suppo rtive Therapy, Ceftriaxone, Renal, Cefazolin, Dialysis